Pemetrexed is also recommended in combination with carboplatin for the first-line treatment of advanced non-small cell lung cancer. However, the relative efficacy or toxicity of pemetrexed-cisplatin versus pemetrexed-carboplatin has not been established beyond what is generally thought about cisplatin or carboplatin doublet drug therapy.
Thank You!
Thank You for your valuable time. We have received your details and will get back to you shortly.
SAINTROY LIFESCIENCE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |